Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global huber needle market is expected to grow in the forecast period of 2022-2027 at a CAGR of 6%. The market is estimated to reach a value of nearly USD 60 million by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The huber needle industry is growing at a healthy pace, and a significant number of players are expected to enter the global market. North America has been a major market for huber needle in the past years and is expected to retain its position in the forecast period as well. The growth of the North American market can be attributed to the rising numbers of chronic patients. Huber needle has been adopted in chemotherapy, transfusion, and blood sampling due to its easy accessibility. It is finding increasing usage in intravascular cancer treatments, thus, further aiding the huber needle industry growth in North America.
Apart from North America, Europe, and the Asia Pacific regions have also exhibited significant growth in the historical period. Within the Asia Pacific, India and China observed a rapid growth in the recent years. The growing healthcare infrastructure and rising health awareness are expected to augment the huber needle industry growth in these regions in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A Huber needle is a hollow needle specifically designed for chemotherapies and transfusions. It contains septum (silicon membrane) through which drugs can be injected. Straight huber needles are preferred for short term procedures, whereas curved huber needles are more convenient for repetitive vascular access procedures. The huber needles are used in treatments of various chronic diseases and for nutritional fluid delivery.
Based on type, the market is classified into:
Based on application, the market is segmented into:
Based on end-use, the market is categorised into:
The EMR report looks into the regional markets of North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is being driven by a significant rise in the cases of chronic diseases and cancers as chemotherapy, blood sampling, and transfusion require a huber needle. Hence, the increasing occurrences of such diseases are adding to the demand for huber needle. The growing adoption of these needles in the treatment of hepatitis and HIV is expected to bolster the huber needle industry in the coming years. Increasing investments in healthcare infrastructure are also predicted to influence the market positively in the forecast period. The huber needle industry is expected to be aided by government regulations on needle stick injuries to ensure patient safety. Furthermore, the usage of a curved huber needle for nutritional fluid delivery is expected to bolster the market over the forecast period.
The report presents a detailed analysis of the following key players in the global huber needle industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2020 |
Historical Period | 2017-2021 |
Forecast Period | 2022-2027 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Application, End Use, Region |
Breakup by Type | Straight, Curved |
Breakup by Application | Dialysis, Blood Transfusions, IV Cancer Treatment, Lap-Band Adjustments, Home Parenteral Nutrition, Others |
Breakup by End Use | Hospitals, Oncology Centres, Clinics, Ambulatory Surgical Centres, Others |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Baxter International Inc, Becton, Dickinson and Company, NIPRO Corporation, B. Braun Medical Inc., Smiths Medical Group Limited, Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Huber Needle Market Analysis
8.1 Key Industry Highlights
8.2 Global Huber Needle Historical Market (2017-2021)
8.3 Global Huber Needle Market Forecast (2022-2027)
8.4 Global Huber Needle Market by Type
8.4.1 Straight
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Curved
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.5 Global Huber Needle Market by Application
8.5.1 Dialysis
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Blood Transfusions
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 IV Cancer Treatment
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Lap-Band Adjustments
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Home Parenteral Nutrition
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Others
8.6 Global Huber Needle Market by End Use
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Oncology Centres
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Clinics
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.6.4 Ambulatory Surgical Centres
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2017-2021)
8.6.4.3 Forecast Trend (2022-2027)
8.6.5 Others
8.7 Global Huber Needle Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Baxter International Inc
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Becton, Dickinson and Company
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 NIPRO Corporation
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 B. Braun Medical Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Smiths Medical Group Limited
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Huber Needle Market: Key Industry Highlights, 2016 and 2026
2. Global Huber Needle Historical Market: Breakup by Type (USD Million), 2017-2021
3. Global Huber Needle Market Forecast: Breakup by Type (USD Million), 2022-2027
4. Global Huber Needle Historical Market: Breakup by Application (USD Million), 2017-2021
5. Global Huber Needle Market Forecast: Breakup by Application (USD Million), 2022-2027
6. Global Huber Needle Historical Market: Breakup by End Use (USD Million), 2017-2021
7. Global Huber Needle Market Forecast: Breakup by End Use (USD Million), 2022-2027
8. Global Huber Needle Historical Market: Breakup by Region (USD Million), 2017-2021
9. Global Huber Needle Market Forecast: Breakup by Region (USD Million), 2022-2027
10. North America Huber Needle Historical Market: Breakup by Country (USD Million), 2017-2021
11. North America Huber Needle Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Europe Huber Needle Historical Market: Breakup by Country (USD Million), 2017-2021
13. Europe Huber Needle Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Asia Pacific Huber Needle Historical Market: Breakup by Country (USD Million), 2017-2021
15. Asia Pacific Huber Needle Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Latin America Huber Needle Historical Market: Breakup by Country (USD Million), 2017-2021
17. Latin America Huber Needle Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Middle East and Africa Huber Needle Historical Market: Breakup by Country (USD Million), 2017-2021
19. Middle East and Africa Huber Needle Market Forecast: Breakup by Country (USD Million), 2022-2027
20. Global Huber Needle Market Structure
The market is projected to grow at a CAGR of 6% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 60 million by 2026.
The major market drivers include a rising number of chronic patients, growing usage of the product in nutritional delivery, and rising government regulations on needle stick injuries.
The key trends steering the market include the usage of a curved huber needle for repetitive vascular access procedures.
North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa are the major regional markets for huber needle.
The major types of huber needles are straight and curved needles.
The major indication segments within the market are dialysis, blood transfusions, IV cancer treatment, lap-band adjustments, and home parental nutrition, among others.
The significant end-use sectors within the market are hospitals, ambulatory surgical centers, oncology centers, and clinics, among others.
Baxter International Inc., Becton, Dickinson, and Company, NIPRO Corporation, B. Braun Medical Inc., and Smiths Medical Group Limited, among others, are the key industry players for huber needle.
The global huber needle market is being driven by the rising occurrences of chronic illnesses. Aided by the rapid improvements in the healthcare infrastructure, the market is expected to witness a healthy growth in the forecast period of 2022-2027, growing at a CAGR of 6% and is projected to attain about USD 60 million by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the huber needle industry can be broadly segmented into straight and curved. On the basis of application, the market is divided into dialysis, blood transfusions, IV cancer treatment, lap-band adjustments, and home parental nutrition, among others. On the basis of end-use, the market is categorised into hospitals, ambulatory surgical centres, oncology centres, and clinics. The major regional markets for the huber needle are North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. The key players in the above market include Baxter International Inc., Becton, Dickinson, and Company, NIPRO Corporation, B. Braun Medical Inc., and Smiths Medical Group Limited.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.